MRM Proteomics

6 articles about MRM Proteomics

• MRM Proteomics, Inc. and Agilent Technologies, Inc.: A Collaboration for Progress

  2/3/2022

  MRM Proteomics, Inc. and Agilent Technologies Inc. are excited to announce their new co-marketing agreement aimed to further advance the capabilities of quantitative proteomic applications and thereby help the scientific community make impactful, novel scientific discoveries.

• MRM Proteomics and Biodesix Partner to Develop Precision Lung Cancer Diagnostics

  1/28/2019

  MRM Proteomics Inc. and Biodesix® have inked a partnership to create novel assays to answer critical clinical questions within the lung cancer continuum of care.

• MRM Proteomics Inc and Exactis Innovation Partner to Establish Unique Clinical Proteomics Tools for Precision Medicine

  9/12/2018

  MRM Proteomics is partnering with Exactis Innovation to develop and validate a clinical proteomic test that will provide clinicians and scientists with the ability to identify immune signatures and tumour mutation profiles to better match patients with the most effective treatments.

• Agilent Technologies Inc. Signs Co-Marketing Agreement With MRM Proteomics To Advance Quantitative Proteomics Solutions

  7/24/2014

• PROOF Centre and MRM Proteomics Collaborate With the Jain Foundation to Identify Blood-Based Biomarkers of LGMD2B/Miyoshi Muscular Dystrophy

  10/16/2013

• Agilent Technologies Inc. and MRM Proteomics Introduce First Commercial Kits for Quality Control of MRM-Based Quantitative Plasma Proteomic Workflows

  10/9/2013